Recently, Hanji Huang et al. discovered a strong link between RBM15 and the formation of osteosarcoma metastasis as well as reduced patient survival, suggesting that RBM15 may be a biomarker used to predict the prognosis of patients with osteosarcoma [162]. Here, RBM15 is linked to osteosarcoma.